Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) EBITDA (2020 - 2025)

Privia Health has reported EBITDA over the past 6 years, most recently at $11.4 million for Q4 2025.

  • Quarterly results put EBITDA at $11.4 million for Q4 2025, up 108.86% from a year ago — trailing twelve months through Dec 2025 was $35.0 million (up 93.38% YoY), and the annual figure for FY2025 was $35.0 million, up 93.38%.
  • EBITDA for Q4 2025 was $11.4 million at Privia Health, down from $14.6 million in the prior quarter.
  • Over the last five years, EBITDA for PRVA hit a ceiling of $14.6 million in Q3 2025 and a floor of -$192.9 million in Q2 2021.
  • Median EBITDA over the past 5 years was $4.5 million (2024), compared with a mean of -$8.0 million.
  • Biggest five-year swings in EBITDA: tumbled 3017.54% in 2021 and later soared 387.56% in 2025.
  • Privia Health's EBITDA stood at -$19.1 million in 2021, then soared by 113.33% to $2.5 million in 2022, then plummeted by 32.49% to $1.7 million in 2023, then soared by 219.11% to $5.5 million in 2024, then soared by 108.86% to $11.4 million in 2025.
  • The last three reported values for EBITDA were $11.4 million (Q4 2025), $14.6 million (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.